Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to New England Biolabs for $1,002,120.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44GM105125-02 | Phase II | 1,002,120 | ||||||||
A STTR Phase I contract was awarded to New England Biolabs for $213,422.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI092969-01A1 | Phase I | 213,422 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $218,685.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44GM100560-01 | Phase I | 218,685 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $267,417.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44GM095209-01 | Phase I | 267,417 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $278,797.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44GM096723-01A1 | Phase I | 278,797 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $251,006.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44GM105132-01 | Phase I | 251,006 | ||||||||
A SBIR Phase II contract was awarded to New England Biolabs for $960,499.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44GM086930-02 | Phase II | 960,499 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $99,117.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM071155-01 | Phase I | 99,117 | ||||||||
A SBIR Phase II contract was awarded to New England Biolabs for $568,340.0 USD from the U.S. Department of Health & Human Services. | SBIR | 9R42HG003976-02 | Phase II | 568,340 | ||||||||
A STTR Phase II contract was awarded to New England Biolabs for $761,592.0 USD from the U.S. Department of Health & Human Services. | STTR | 4R42GM105097-02 | Phase II | 761,592 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $104,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R41GM070212-01 | Phase I | 104,000 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $256,651.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44GM105125-01 | Phase I | 256,651 | ||||||||
A SBIR Phase II contract was awarded to New England Biolabs for $874,892.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44GM100560-02 | Phase II | 874,892 | ||||||||
A SBIR Phase II contract was awarded to New England Biolabs for $640,759.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44GM096723-02 | Phase II | 640,759 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM073345-01 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $233,095.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM086930-01 | Phase I | 233,095 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $132,223.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM081890-01 | Phase I | 132,223 | ||||||||
A STTR Phase I contract was awarded to New England Biolabs for $104,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41GM070212-01 | Phase I | 104,000 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $107,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43GM083413-01 | Phase I | 107,000 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $97,515.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI061865-01 | Phase I | 97,515 | ||||||||
A SBIR Phase II contract was awarded to New England Biolabs for $497,285.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44GM087021-02 | Phase II | 497,285 | ||||||||
A SBIR Phase I contract was awarded to New England Biolabs for $107,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44GM087021-01 | Phase I | 107,000 | ||||||||
A SBIR Phase II contract was awarded to New England Biolabs for $903,660.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44GM095209-02 | Phase II | 903,660 | ||||||||
A SBIR Phase II contract was awarded to New England Biolabs for $392,231.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase II | 392,231 | |||||||||
A SBIR Phase II contract was awarded to New England Biolabs for $304,431.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase II | 304,431 |